Skip to main content
. 2022 Sep 22;11:e78233. doi: 10.7554/eLife.78233

Appendix 1—figure 13. Measured weekly crude seroprevalence compared to the crude seroprevalence reconstructed by our proposed seroreversion correction model.

Appendix 1—figure 13.

The high similarity between both quantities shows that the seroprevalence estimated by the model is compatible with the observations.

HHS Vulnerability Disclosure